Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, van den Berg LH. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol. 2012;124:339–52.

Article  PubMed  CAS  Google Scholar 

Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011;7:603–15.

Article  PubMed  CAS  Google Scholar 

DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245–56.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–68.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.

Article  PubMed  CAS  Google Scholar 

Kwiatkowski TJ, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205–8.

Article  PubMed  CAS  Google Scholar 

Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208–11.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, et al. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol. 2008;63:535–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40:572–4.

Article  PubMed  CAS  Google Scholar 

Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668–72.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Manzano R, Toivonen JM, Moreno-Martínez L, de la Torre M, Moreno-García L, López-Royo T, et al. What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy. Br J Pharmacol. 2021;178:1279–97.

Article  PubMed  CAS  Google Scholar 

Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, Boncompagni S, et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008;8:425–36.

Article  PubMed  CAS  Google Scholar 

Wong M, Martin LJ. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet. 2010;19:2284–302.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Baskin KK, Winders BR, Olson EN. Muscle as a and quot;Mediator and quot; of systemic metabolism. Cell Metab. 2015;21:237–48.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Reyes ET, Perurena OH, Festoff BW, Jorgensen R, Moore WV. Insulin resistance in amyotrophic lateral sclerosis. J Neurol Sci. 1984;63:317–24.

Article  PubMed  CAS  Google Scholar 

Dedic SIK, Stevic Z, Dedic V, Stojanovic VR, Milicev M, Lavrnic D. Is hyperlipidemia correlated with longer survival in patients with amyotrophic lateral sclerosis? Neurol Res. 2012;34:576–80.

Article  PubMed  Google Scholar 

Shimizu T, Honda M, Ohashi T, Tsujino M, Nagaoka U, Kawata A, et al. Hyperosmolar hyperglycemic state in advanced amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:379–81.

Article  PubMed  CAS  Google Scholar 

Pradat P-F, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, Simon D, et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:166–71.

Article  PubMed  CAS  Google Scholar 

Hubbard RW, Will AD, Peterson GW, Sanchez A, Gillan WW, Tan SA. Elevated plasma glucagon in amyotrophic lateral sclerosis. Neurology. 1992;42:1532–4.

Article  PubMed  CAS  Google Scholar 

Hamasaki H, Takeuchi Y, Masui Y, Ohta Y, Abe K, Yoshino H, et al. Development of diabetes in a familial amyotrophic lateral sclerosis patient carrying the I113T SOD1 mutation. Case Report Neuro Endocrinol Lett. 2015;36:414–6.

PubMed  Google Scholar 

López-Otín C, Galluzzi L, Freije JMP, Madeo F, Kroemer G. Metabolic Control of Longevity. Cell. 2016;166:802–21.

Article  PubMed  Google Scholar 

Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001;191:133–7.

Article  PubMed  CAS  Google Scholar 

Nieves JW, Gennings C, Factor-Litvak P, Hupf J, Singleton J, Sharf V, et al. Association Between Dietary Intake and Function in Amyotrophic Lateral Sclerosis. JAMA Neurol. 2016;73:1425–32.

Article  PubMed  PubMed Central  Google Scholar 

Zhao Z, Sui Y, Gao W, Cai B, Fan D. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model. J Int Med Res. 2015;43:67–79.

Article  PubMed  CAS  Google Scholar 

Pikatza-Menoio O, Elicegui A, Bengoetxea X, Naldaiz-Gastesi N, López de Munain A, Gerenu G, et al. The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis. J Pers Med. 2021;11:671.

Scaricamazza S, Salvatori I, Ferri A, Valle C. Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity? Cells. 2021;10:525.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pascoe AL, Johnston AJ, Murphy RM. Controversies in TWEAK-Fn14 signaling in skeletal muscle atrophy and regeneration. Cell Mol Life Sci. 2020;

Enwere EK, Lacasse EC, Adam NJ, Korneluk RG. Role of the TWEAK-Fn14-cIAP1-NF-κB Signaling Axis in the Regulation of Myogenesis and Muscle Homeostasis. Front Immunol. 2014;5:34.

Article  PubMed  PubMed Central  Google Scholar 

Sato S, Ogura Y, Tajrishi MM, Kumar A. Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction. FASEB J. 2015;29:988–1002.

Article  PubMed  CAS  Google Scholar 

Boyer JG, Ferrier A, Kothary R. More than a bystander: the contributions of intrinsic skeletal muscle defects in motor neuron diseases. Front Physiol. 2013;4:356.

Article  PubMed  PubMed Central  Google Scholar 

Crawford TO, Pardo CA. The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis. 1996;3:97–110.

Article  PubMed  CAS  Google Scholar 

Meijboom KE, Sutton ER, McCallion E, McFall E, Anthony D, Edwards B, et al. Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice. Skelet Muscle. 2022;12:18.

Article  PubMed